| P50 | author | Joseph Hogan | Q43158427 |
| | Philip Chan | Q55523779 |
| P2093 | author name string | Rami Kantor | |
| | Nathan Buziba | |
| | E Jane Carter | |
| | Lameck Diero | |
| | Allison Delong | |
| | Fidelis Mambo | |
| | Wilfred Emonyi | |
| | Eunice Walumbe | |
| | Lydia Kamle | |
| | Sarah Muyonga | |
| P2860 | cites work | Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis | Q24672191 |
| | Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis | Q33950833 |
| | Population-based hematologic and immunologic reference values for a healthy Ugandan population | Q35542336 |
| | Changing antiretroviral therapy in the setting of virologic relapse: review of the current literature | Q36445650 |
| | Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. | Q36539380 |
| | Impact of HIV-1 pol diversity on drug resistance and its clinical implications | Q36639739 |
| | Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy | Q36900004 |
| | Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel | Q37234205 |
| | Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa | Q39240148 |
| | When to switch for antiretroviral treatment failure in resource-limited settings? | Q39556015 |
| | The prevalence of antiretroviral drug resistance in the United States | Q39687529 |
| | Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection | Q41725318 |
| | Discordant immunological and virological responses to antiretroviral therapy | Q44070515 |
| | HIV viral load monitoring in resource-limited regions: optional or necessary? | Q44629379 |
| | Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration | Q45170920 |
| | Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection | Q45770057 |
| | Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring | Q45783388 |
| | Antiretroviral-drug resistance among patients recently infected with HIV. | Q46277555 |
| | Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice | Q46375563 |
| | Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model | Q46623836 |
| | Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy | Q46775070 |
| | The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. | Q50745207 |
| | Relationship between CD4 count and CD4% in HIV-infected people. | Q50911052 |
| | Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy. | Q51771547 |
| | Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. | Q53645693 |
| | Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes | Q56533400 |
| | CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/μL | Q57259695 |
| | Performance of Immunologic Responses in Predicting Viral Load Suppression | Q57259706 |
| | CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men | Q58436713 |
| | Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART | Q59283962 |
| | National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines? | Q60343091 |
| | Viral load testing in resource-limited settings | Q79402192 |
| | Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection | Q80327644 |
| | Monitoring antiretroviral failure in resource-poor settings | Q81161975 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| | misclassification | Q61793526 |
| P304 | page(s) | 454-462 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings | |
| P478 | volume | 49 | |